News | Capricorn Partners | Capricorn Partners

2025

Capricorn Partners launches the Capricorn Healthtech Fund II with a first closing of €51 million

9 January 2025

2024

Minze Health raises US$ 5.3 million in funding to develop Prescription Digital Therapeutics and Drive Commercialization in the US Market

11 October 2024

Thryve secures € 4 million funding to accelerate international growth

2 September 2024

Confo Therapeutics Announces € 60 million Series B Financing to advance pipeline of novel GPCR-Modulating Therapies into clinical development

26 July 2024

2023

Confo Therapeutics enters into collaboration agreement with Daiichi Sankyo to discover novel medicines for CNS diseases

30 March 2023

Confo Therapeutics Announces Global Licensing Agreement with Lilly for Peripheral Pain Candidate, CFTX-1554

2 March 2023

2022

Filip Pintelon to represent Capricorn on the board of iSTAR Medical

30 November 2022

Capricorn Health-tech Fund supports its portfolio company iSTAR Medical entering into a Strategic Alliance with AbbVie for the Treatment of Glaucoma

20 July 2022

Capricorn Partners prepares its future further with a restyled logo and a new website

27 January 2022

2021

iSTAR Medical receives US FDA approval to start pivotal trial for MINIject in glaucoma patients

15 July 2021

Nexstim extends agreement with Canadian distributor and receives order for three NBT® systems

25 May 2021

Nexstim granted authorization for commercial distribution of NBS system in Australia

18 May 2021

1
2
3
4
...
6